Keyword
in
Collection
Date
to
Montrose Voice, No. 331, February 27, 1987
File 004
Citation
MLA
APA
Chicago/Turabian
Montrose Voice, No. 331, February 27, 1987 - File 004. 1987-02-27. University of Houston Libraries. University of Houston Digital Library. Web. October 24, 2020. https://digital.lib.uh.edu/collection/montrose/item/2313/show/2283.

Disclaimer: This is a general citation for reference purposes. Please consult the most recent edition of your style manual for the proper formatting of the type of source you are citing. If the date given in the citation does not match the date on the digital item, use the more accurate date below the digital item.

(1987-02-27). Montrose Voice, No. 331, February 27, 1987 - File 004. Montrose Voice. University of Houston Libraries. Retrieved from https://digital.lib.uh.edu/collection/montrose/item/2313/show/2283

Disclaimer: This is a general citation for reference purposes. Please consult the most recent edition of your style manual for the proper formatting of the type of source you are citing. If the date given in the citation does not match the date on the digital item, use the more accurate date below the digital item.

Montrose Voice, No. 331, February 27, 1987 - File 004, 1987-02-27, Montrose Voice, University of Houston Libraries, accessed October 24, 2020, https://digital.lib.uh.edu/collection/montrose/item/2313/show/2283.

Disclaimer: This is a general citation for reference purposes. Please consult the most recent edition of your style manual for the proper formatting of the type of source you are citing. If the date given in the citation does not match the date on the digital item, use the more accurate date below the digital item.

URL
Embed Image
Compound Item Description
Title Montrose Voice, No. 331, February 27, 1987
Contributor
  • McClurg, Henry
  • Wyche, Linda
Publisher Community Publishing Company
Date February 27, 1987
Language English
Subject
  • LGBTQ community
  • LGBTQ people
  • Gay liberation movement
Place
  • Houston, Texas
Genre
  • newspapers
Type
  • Text
Identifier OCLC: 22329406
Collection
  • University of Houston Libraries Special Collections
  • LGBT Research Collection
  • Montrose Voice
Rights In Copyright
Note This item was digitized from materials loaned by the Gulf Coast Archive and Museum (GCAM).
Item Description
Title File 004
Transcript Hormone Shows Promise of Treating Cancer, AIDS FEBRUARY 27, 1987/MONTROSE VOICE 3 By Larry Doyle UPI Science Writer CHICAGO—A major development in the fight against cancer and AIDS may he a genetically engineered protein that cannot cure either disease but can strengthen the immune system, a scientist said this month. "We're very excited," said Nicholas Plotnikoff, a neuropharmacologist with Oral Roberts University School of Medicine in Tulsa, Okla. "This drug appears to work and has no toxic side effects at all as far as we can determine, which is virtually unheard of." While the drug—methione enka- phalin—cannot cure either cancer or AIDS, it can enhance the body's ability to fight the diseases and prevent infections that often accompany them, Plotnikoff said Feb. 15. Plotnikoff discussed results of clinical trials of the hormone at the annual meeting of the American Association for the Advancement of Science. Other researchers at the protein drug symposium touted genetic engineering as providing doctors with new tools to treat tumors, heart attacks and wounds. "The development of techniques to transfer DNA into bacteria has made it relatively easy to produce enzymes, regulating factors and other proteins in large quantities," said Wolfgang Sadee, professor of pharmaceutical chemistry at the University of California at San Francisco. "These proteins open up an entirely new approach to therapy," he said, "and also provide novel insights into the physiological mechanisms of the major diseases of mankind." Plotnikoff and his colleagues have investigated a group of proteins—called prohormones because they act as precursors to the body's major biological regulators—which interact with white blood cells to either depress or increase immune response. Methione enkaphalin, one such prohormone, has been tested on about a dozen patients with cancer and a dozen others with AIDS-related complex, a less severe form of acquired immune deficiency syndrome that often but not always develops into the deadly disease. "We've been treating the ARC patients for a year and none of them have developed any opportunistic infections and none have gone on to develop AIDS, both of which (are) rather surprising," Plotnikoff said. The results on cancer patients were less encouraging, he said, in that no significant reductions were seen in the advanced cases. But the drug did bolster the patients' immune systems and did montrose VOICE HOUSTON. TEXAS ISSUE 331 FRIDAY. FEBRUARY 27. 1987 Published weekly Community Publishing Company 408 Avondale Houston, TX 77006 Phone (713) 529-8490 Contents copyright 1987 Office hours: 8am-6pm Henry McClurg/pub..s..e.--«f..or Linda Wye he/managing editor David Roomfort/D'oducfion Elroy Forbes/soc.a. director Sheri Cohen Darbonne/news SUBSCRIPTIONS (713) 529-8490 ADVERTISING SALES DEPARTMENT (713) 529-8490 Jerry Mulholland/aoVerr.si Ken Boge/accoimt execute POSTMASTER Send address corrections lo 408 Avondale. Houston. TX 77006-3028 Subscription rele in US toy Voice carrier or US Mail) $1.25 per week (up to 2 Issues), $65 per year (52 weeks), or $32 50 per six months (26 weeks) National advertising representative Rtvendell Marketing. PO Bon 1268, Plaml.eld. NJ 07061, (201) 754-4348 Final advertising deadline All display ads 5pm 2 days prior lo publication date All classified ads 2pm 1 day prior to publication date Notice to advertisers Advertising rate schedule Eight-A was effective April 11.1986 Responsibility We do not assume financial responsibility lor claims by advertisers but readers are asked to advise Ihe newspaper ot any suspicion ol Iradulenl or deceptive advertising and suspicions will be investigated News service United Press International prevent other infections that often afflict cancer patients, such as pneumonia. "I see this as a possible adjunct treatment for cancer patients coming off chemotherapy," Plotnikoff said. "It could be very helpful in preventing complications." Plotnikoff said plans are underway to expand the testing of methione enkaphalin on ARC-patients. Ideally, he said, the drug would be tested in conjunction with an anti-viral agent such as the experimental AZT, which reduces spread ofthe disease but does not restore immune function. Need a Car Today? Call Ralph Gilbert at Texas Brokers • 200 Cars to Choose From • Your Job is Your Credit • Instant Financing- Low Monthly Payments $100 off with this ad 1433 N. Shepherd 868-2365 CT* At Pardi Gras Nobody Does It Like \ % 1022 Westheimer 528-8851 Music by Larissa Thompson co CL S- 3 Morning: 7am-Noon Monday-Saturday Afternoon: 6pm-8pm Monday-Friday W Evening: ll:30pm-12:30am Every Night Can Beer SI 25 Draf! Beer 75C Well Drinks SI 75 Shots Si 25
File Name uhlib_22329406_n331_003.jpg